Richard D. Carvajal, MD, medical oncologist, Memorial Sloan-Kettering Cancer Center, describes the use of selumetinib in patients with advanced uveal melanoma.
An Overview of the Treatment of Melanoma
FDA Approves Both Dabrafenib and Trametinib for Advanced Melanoma
Seth A. Wander, MD, PhD; Kara M. Schenk, MD
Patrick I. Borgen, MD; Joshua Feinberg, MD; Gary Schwartz, MD, FASA
Marla D. Lipsyc-Sharf, MD; Yan Ji, MD
Marla D. Lipsyc-Sharf, MD; Kimberly Ku, MD
Patrick I. Borgen, MD; Reshma Jagsi, MD, DPhil; Hope S. Rugo, MD, FASCO
Patrick I. Borgen, MD; E. Shelley Hwang, MD, MPH; Mark E. Robson, MD
Heather McArthur, MD, MPH; Komal Jhaveri, MD, FACP; Sara Tolaney, MD, MPH; Seth A. Wander, MD, PhD
Rita Nanda, MD; William Gradishar, MD, FASCO, FACP; Komal Jhaveri, MD, FACP; Kevin Kalinsky, MD, MS
Rebecca Shatsky, MD; Kelly McCann, MD, PhD; Michelle L. Taylor, ANP-BC
Hope S. Rugo, MD, FASCO; Sara Hurvitz, MD, FACP; Jennifer Litton, MD, MHCM; Heather McArthur, MD, MPH
Joyce O’Shaughnessy, MD; William Gradishar, MD, FASCO, FACP; Heather McArthur, MD, MPH; Eleni Anastasia Tousimis, MD, MBA, FACS
May 22, 2026
Reshma Jagsi, MD, DPhil; Kevin Kalinsky, MD, MS; Hope S. Rugo, MD, FASCO; Alastair Thompson, MD, MBChB, BSc (Hons), FRCS (Ed), FACS
William J. Gradishar, MD, FASCO, FACP; Laura Huppert, MD; Yuan Yuan, MD, PhD
Aditya Bardia, MD, MPH, FASCO; Joyce O’Shaughnessy, MD; Hope S. Rugo, MD; Paolo Tarantino, MD
Joyce O’Shaughnessy, MD; Matthew P. Goetz, MD; Hope S. Rugo, MD, FASCO
Aditya Bardia, MD, MPH, FASCO; Erika P. Hamilton, MD; Virginia Kaklamani, MD, DSc
Aditya Bardia, MD, MPH, FASCO; Erika P. Hamilton, MD
Virginia Kaklamani, MD, DSc; Tiffany A. Traina, MD, FASCO
Filipa Lynce, MD; Rita Nanda, MD
Joyce O’Shaughnessy, MD
Aditya Bardia, MD, MPH, FASCO; Erika P. Hamilton, MD; Virginia Kaklamani, MD, DSc; Filipa Lynce, MD; Rita Nanda, MD; Tiffany A. Traina, MD, FASCO
Aditya Bardia, MD, MPH, FASCO; Erika P. Hamilton, MD; Tiffany A. Traina, MD, FASCO
Ana C. Garrido-Castro, MD; Pedram Razavi, MD, PhD
